NAIROBI, Oct. 16 (Xinhua) -- Beaming with excitement, dozens of patients braved the humid afternoon weather to queue for a Chinese-manufactured anti-malaria injectable drug at a private hospital in the western Kenyan county of Kisumu, where the tropical disease is endemic.
Manufactured by the Chinese pharmaceutical company Fosun Pharma, the injectable artesunate has significantly improved malaria treatment in Kisumu and the wider Lake Victoria basin, according to local health officials and doctors.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
